Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight 'Ahead of Extended 11/22 PDUFA Date'
Tweet Send to a Friend
(Updated - September 1, 2026 6:31 AM EDT)
Piper Sandler analyst Edward Tenthoff upgraded Capricor Therapeutics (NASDAQ: CAPR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Edward Tenthoff upgraded Capricor Therapeutics (NASDAQ: CAPR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
